BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38813360)

  • 1. Salivary levels of azurocidin and soluble azurophilic granules in periodontal disease.
    Jasim FS; Al-Ghurabi BH; Abdulameer LA
    J Med Life; 2024 Feb; 17(2):205-209. PubMed ID: 38813360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Colony Stimulating Factor-1 and Interleukin-34 in Periodontal Disease.
    Martinez GL; Majster M; Bjurshammar N; Johannsen A; Figueredo CM; Boström EA
    J Periodontol; 2017 Aug; 88(8):e140-e149. PubMed ID: 28474967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azurocidin in gingival crevicular fluid as a potential biomarker of chronic periodontitis.
    Nalmpantis D; Gatou A; Fragkioudakis I; Margariti A; Skoura L; Sakellari D
    J Periodontal Res; 2020 Apr; 55(2):209-214. PubMed ID: 31608993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary citrullinated proteins in rheumatoid arthritis and associated periodontal disease.
    Tar I; Csősz É; Végh E; Lundberg K; Kharlamova N; Soós B; Szekanecz Z; Márton I
    Sci Rep; 2021 Jun; 11(1):13525. PubMed ID: 34188155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of salivary procalcitonin levels in different periodontal diseases.
    Hendek MK; Erdemir EO; Kisa U
    J Periodontol; 2015 Jun; 86(6):820-6. PubMed ID: 25703733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage activating factor: A potential biomarker of periodontal health status.
    Zhang P; Fan Y; Li Q; Chen J; Zhou W; Luo Y; Zhang J; Su L; Xue X; Zhou X; Feng Y
    Arch Oral Biol; 2016 Oct; 70():94-99. PubMed ID: 27341461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary nitric oxide levels in inflammatory periodontal disease - a case-control and interventional study.
    Parwani SR; Chitnis PJ; Parwani RN
    Int J Dent Hyg; 2012 Feb; 10(1):67-73. PubMed ID: 21564536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statherin and alpha-amylase levels in saliva from patients with gingivitis and periodontitis.
    Parlak HM; Buber E; Gur AT; Karabulut E; Akalin FA
    Arch Oral Biol; 2023 Jan; 145():105574. PubMed ID: 36395562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary bactericidal/permeability-increasing protein: A novel inflammatory marker associated with periodontitis.
    Demirci MB; Daltaban Ö; Üstün K
    Clin Oral Investig; 2023 Jun; 27(6):3159-3167. PubMed ID: 36805805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation.
    Özcan E; Saygun NI; Serdar MA; Kurt N
    Clin Oral Investig; 2015 May; 19(4):921-8. PubMed ID: 25164155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics analysis in saliva from periodontally healthy, gingivitis and periodontitis patients.
    Alamri MM; Williams B; Le Guennec A; Mainas G; Santamaria P; Moyes DL; Nibali L
    J Periodontal Res; 2023 Dec; 58(6):1272-1280. PubMed ID: 37787434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of salivary arginine catabolic activity through periodontal therapy.
    Pereira AL; Cortelli SC; Aquino DR; Franco GC; Cogo K; Rodrigues E; Costa FO; Holzhausen M; Cortelli JR
    Quintessence Int; 2012 Oct; 43(9):777-87. PubMed ID: 23041992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary histone deacetylase in periodontal disease: A cross-sectional pilot study.
    Liaw A; Liu C; Bartold M; Ivanovski S; Han P
    J Periodontal Res; 2023 Apr; 58(2):433-443. PubMed ID: 36717759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease.
    Barnes VM; Kennedy AD; Panagakos F; Devizio W; Trivedi HM; Jönsson T; Guo L; Cervi S; Scannapieco FA
    PLoS One; 2014; 9(8):e105181. PubMed ID: 25133529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local and systemic levels of aMMP-8 in gingivitis and stage 3 grade C periodontitis.
    Keles Yucel ZP; Afacan B; Emingil G; Tervahartiala T; Kose T; Sorsa T
    J Periodontal Res; 2020 Dec; 55(6):887-894. PubMed ID: 32790178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of salivary leucine-rich alpha-2 glycoprotein (LRG) and C-reactive protein (CRP) in humans with periodontal health or periodontal disease.
    Özer E; Yilmaz HE; Narin F; Sağlam M
    J Periodontal Res; 2024 Apr; 59(2):387-394. PubMed ID: 38126217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis.
    Leppilahti JM; Hernández-Ríos PA; Gamonal JA; Tervahartiala T; Brignardello-Petersen R; Mantyla P; Sorsa T; Hernández M
    J Clin Periodontol; 2014 Apr; 41(4):348-56. PubMed ID: 24382144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary interleukin-1β as a biomarker to differentiate between periodontal health, gingivitis, and periodontitis.
    Abdullameer MA; Abdulkareem AA
    Minerva Dent Oral Sci; 2023 Oct; 72(5):221-229. PubMed ID: 37162330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is sialic acid a promising marker for periodontal diseases?
    Oktay S; Bal OO; Kuru L; Yarat A; Noyan U
    Niger J Clin Pract; 2020 May; 23(5):603-609. PubMed ID: 32367865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation.
    Sculley DV; Langley-Evans SC
    Clin Sci (Lond); 2003 Aug; 105(2):167-72. PubMed ID: 12650638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.